Generated Narrative: CodeSystem v3-substanceAdminSubstitution

Language: en

Properties

This code system defines the following properties for its concepts

Name	Code	URI	Type	Description
Specializes	Specializes		Coding	The child code is a more narrow version of the concept represented by the parent code. I.e. Every child concept is also a valid parent concept. Used to allow determination of subsumption. Must be transitive, irreflexive, antisymmetric.
Generalizes	Generalizes		Coding	Inverse of Specializes. Only included as a derived relationship.
internalId	internalId	http://terminology.hl7.org/CodeSystem/utg-concept-properties#v3-internal-id	code	The internal identifier for the concept in the HL7 Access database repository.
Not Selectable	notSelectable	http://hl7.org/fhir/concept-properties#notSelectable	boolean	Indicates that the code is abstract - only intended to be used as a selector for other concepts
Status	status	http://hl7.org/fhir/concept-properties#status	code	Designation of a concept's state. Normally is not populated unless the state is retired.

Concepts

This case-sensitive code system http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution defines the following codes in a Is-A hierarchy:

Lvl	Code	Display	Definition	internalId	Not Selectable	Status
1	_ActSubstanceAdminSubstitutionCode	ActSubstanceAdminSubstitutionCode	Substitution occurred or is permitted with another product that may potentially have different ingredients, but having the same biological and therapeutic effects. \n	21284	true	active
2	E	equivalent	Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product. \n	23107		active
3	EC	equivalent composition	Substitution occurred or is permitted with another product that is a: \n \n pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester \n pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration \n \n Examples: \n \n Pharmaceutical alternative: Erythromycin Ethylsuccinate for Erythromycin Stearate \n Pharmaceutical equivalent: Lisonpril for Zestril \n \n	23108		active
4	BC	brand composition	Substitution occurred or is permitted between equivalent Brands but not Generics \n Examples: \n \n Zestril for Prinivil \n Coumadin for Jantoven \n \n	23109		active
4	G	generic composition	Substitution occurred or is permitted between equivalent Generics but not Brands \n Examples: \n \n Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp) \n \n	16623		active
3	TE	therapeutic alternative	Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile. \n Examples: \n \n ranitidine for Tagamet \n \n	16624		active
4	TB	therapeutic brand	Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics \n \n \n Examples: \n \n Zantac for Tagamet \n \n	23105		active
4	TG	therapeutic generic	Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands \n \n \n Examples: \n \n Ranitidine for cimetidine \n \n	23106		active
2	F	formulary	This substitution was performed or is permitted based on formulary guidelines. \n	16625		active
2	N	none	No substitution occurred or is permitted. \n	16622		active